Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LZM012 in Moderate to Severe Plaque Psoriasis
NCT07746479Phase 3Completed
- Sponsor
- Livzon Pharmaceutical Group Inc.
- Start
- Jun 2025
- Primary completion
- Jan 2026
- Countries
- 1
01
Overview
A Phase 3 trial of lzm012 in plaque psoriasis, sponsored by Livzon Pharmaceutical Group Inc.. Started Jun 2025; status: completed.
02
Drugs
lzm012
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT07746479.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07746479.